These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8416499)

  • 1. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
    Watson BM; Piercy SA; Plotkin SA; Starr SE
    Pediatrics; 1993 Jan; 91(1):17-22. PubMed ID: 8416499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.
    Dennehy PH; Reisinger KS; Blatter MM; Veloudis BA
    Pediatrics; 1991 Sep; 88(3):604-7. PubMed ID: 1881743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity and clinical reinfections following varicella vaccine in healthy children.
    Johnson C; Rome LP; Stancin T; Kumar ML
    Pediatrics; 1989 Sep; 84(3):418-21. PubMed ID: 2549498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 14. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
    Vessey SJ; Chan CY; Kuter BJ; Kaplan KM; Waters M; Kutzler DP; Carfagno PA; Sadoff JC; Heyse JF; Matthews H; Li S; Chan IS
    J Pediatr; 2001 Aug; 139(2):297-304. PubMed ID: 11487760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
    White CJ; Kuter BJ; Hildebrand CS; Isganitis KL; Matthews H; Miller WJ; Provost PJ; Ellis RW; Gerety RJ; Calandra GB
    Pediatrics; 1991 May; 87(5):604-10. PubMed ID: 1850506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.